Sludge Watch ==> CANCER RESEARCH: MISSPENT MONEY, WASTED EFFORTS AND UNCONSCIONABLE PROFITS

[Maureen Reilly]

CANCER RESEARCH: MISSPENT MONEY, WASTED EFFORTS AND UNCONSCIONABLE PROFITS
Malignancies
By ANDREW NIKIFORUK, The Globe and Mail, November 17, 2007

Book review of:
THE SECRET HISTORY OF THE WAR ON CANCER
By Devra Davis

(Basic Books, 505 pages, $33.50)

In 1936, the world's cancer experts assembled in Brussels to talk shop. The 
gathering heard a lot about workshop hazards and environmental toxins. A 
British scientist, who had studied identical twins, argued that cancer 
wasn't inherited, but mostly the product of early chemical exposures in 
life. A meticulous Argentine showed how sunlight combined with hydrocarbons 
could sprout tumours on rats. Others explained how regular exposure to the 
hormone estrogen prompted male rodents to grow unseemly breasts. Everyone 
agreed that arsenic and benzene were workplace killers, too.

Since then, the cancer establishment has retreated from the truth faster 
than Canada's commitment to a greener country. What began as sincere 
investigation into the economic root causes of a complex set of 200 
different diseases, at the turn of the 20th century, quickly degenerated 
into a single-minded focus on treatments after the Second World War, argues 
Devra Davis, one of North America's sharpest epidemiologists (her previous 
book, When Smoke Ran Like Water, was a finalist for the National Book 
Award).

In the process, industry and its propaganda hit men have used every 
opportunity to discredit, dismiss or disparage information on cancer hazards 
in the workplace or at home. So let me warn comfortable readers here and 
now. This courageous and altogether horrible book is about as unsettling as 
it can get. It painstakingly documents such a persistently foul pattern of 
deceit and denial that I often wanted to throw it against a wall and scream.

Furthermore, Davis's hair-raising investigation - in what is easily the most 
important science book of the year - will rob you of any lingering, 
Disney-like fantasies you might have entertained about the nobility of 
cancer fundraising campaigns. And if you have lost a relative or friend to a 
malignant tumour (odds are you have), Davis will make you weep again, 
knowing that fraud and outright criminal neglect have turned a 40-year-long 
medical war into a questionable $70-billion charade.

Even Davis can't hide her own disbelief at times: "Astonishing alliances 
between naive or far too clever academics and folks with major economic 
interests in selling potentially cancerous materials have kept us from 
figuring out whether or not many modern products affect our chances of 
developing cancer." She then diligently documents, for example, how some of 
the world's most prominent cancer researchers, such as the late Sir Richard 
Doll, the epidemiologist who was instrumental in linking smoking to health 
problems, secretly worked for chemical firms without disclosing these ties 
when publishing studies.

Davis, a modern scientist committed to moral clarity, knows her stuff and 
then some. After decades of front-line battles against air polluters, she 
now heads the world's first Centre on Environmental Oncology at the 
University of Pittsburgh Cancer Institute. She too has smelled and felt 
cancer firsthand, having lost two parents and many friends, including the 
comic Andrea Martin, to the disease. She shines, in short, with a burning 
indignation about the abuse of power in medicine.

Her angry history of the way free and open discourse on cancers in the 
workplace has become as elusive as meaningful political debates reveals the 
rot with the bluntness of a chemo treatment. When men who bottled liquid 
lead as a gasoline additive in the 1920s started to drop like flies, General 
Motors blamed the workers and called lead a "natural contaminant." When 
dye-makers at DuPont got bladder cancer from working with benzidine in the 
1930s, the company, like an errant spouse, first denied the findings. Then 
they refused to record cases. Finally, they suppressed or delayed publishing 
the results.

After inhaling tar and poisonous fumes from coke ovens, black steel workers 
succumbed to waves of lung cancer in the 1950s. Yet industry argued that 
blacks were just more vulnerable to lung-consuming tumours. It took an 
enterprising study of dying Mormon coke-oven workers to challenge the lie. 
Damning studies on the health of asbestos workers couldn't find a home in 
the 1930s, and to this day, Canada shamefully remains an exporter of the 
lung destroyer.

Benzene, a true-blue leukemia-maker that can cause workers to bleed out, has 
been the subject of 100 years of deceit and denial. When Myron Mehlman, a 
toxicologist with Mobil Oil, told Japanese officials in 1989 that gasoline 
with 5-per-cent benzene was damned dangerous and shouldn't be sold, the 
company fired him. Davis reports that ExxonMobil, ConocoPhillips and Shell 
have invested $27-million in China to "contradict earlier claims that link 
exposure to low- and mid-levels of benzene to cancers and other diseases."

In 1986, researcher William Fayerweather put together a computerized system 
for tracking the health of every worker at DuPont's chemical plants. Davis 
found that "neither he nor his system any longer work for DuPont." She 
reports that men and women who produced computer chips for IBM are now dying 
young from cancers of the breast, bone marrow and kidney.

While China now leads a global economic boom, it's also exploring new 
opportunities for cancer. Even its secretive, Ottawa-like government now 
concedes that the country's industries use the nation's rivers as industrial 
urinals. Not surprisingly, China now lists cancer as its number-one killer.

Many of Davis's findings simply stunned me. Consider the invasion of 
computerized imaging technology (CT scans) in modern medicine. Since its 
invention in the 1970s, CT scanning has become a $100-billion industry that 
creates nifty three-dimensional images, yet exposes patients to radiation. 
CT scans have become such a favoured technology that one in every three 
scans recommended for children is probably unnecessary.

In the last 25 years, the amount of radiation zapping North Americans from 
scanning and the like has increased fivefold. Now ponder this stunner: 
"Modern America's annual exposure to radiation from diagnostic machines is 
equal to that released by a nuclear accident that spewed the equivalent of 
hundreds of Hiroshimas across much of Russia and Eastern Europe." Most 
physicians don't know that a typical CT scan equals 400 chest X-rays. A 
group of researchers at Yale now estimate that radiation from CT scans of 
the head and abdomen will kill 2,500 people a year.

Davis also presents some disturbing data on aspartame, cellphones and 
Ritalin. Armed with what a prominent toxicologist would later describe as 
"uninterpretable and worthless" studies on aspartame, Donald Rumsfeld, then 
CEO of Searle & Co. (since acquired by Monsanto), used his formidable 
political contacts to gain government approval for the food additive in 
1981. Yet the U.S. Air Force still reports that aspartame "can cause serious 
brain problems in pilots." Despite whatever malarkey yo u might have read, 
cellphone users still have double the risk of brain cancer and folks under 
18 years of age really shouldn't be using them. Ritalin, the drug to slow 
kids down, can rearrange an individual's chromosomes, yet in some school 
districts more than 10 per cent of the students are now on the drug. As 
Davis notes, "Highly profitable industries have no incentive to ask whether 
the products on which they depend may have adverse consequences."

Each and every chapter in this book offers a uncomfortable revelation. 
Pioneering research on the deadly effects of tobacco and environmental 
hormones by the Nazis secretly found its way to many of U.S. corporations 
producing the same questionable goods. The American Cancer Society spends 
less than 10 per cent of its billion-dollar budget on independent studies. 
The great Wilhelm Hueper, the bold pathologist who wrote the book on 
"occupational tumours," suffered one indignity after another for simply 
reporting the dangers of uranium mining. And on it goes.

So, the strange reality of cancer fighting truly reads like one of Kafka's 
nightmares. Most of the 100,000 chemicals commonly used in commerce have not 
been tested. Their proliferation in the workplace has created a cancer 
epidemic and a medical-business industry to treat it. Given the toxic nature 
of many cancer treatments, including radiation and chemotherapy, Davis 
claims that cancer researchers and cancer physicians are dying in record 
numbers.

Davis not only sheds light on this darkness, she also opens many hopeful 
doors. She celebrates tough, rural, blue-collar mothers who have taken on 
the companies that have riddled their children with cancer-makers. And she 
welcomes groups such as Health Care Without Harm, a novel coalition focused 
on getting toxic products out of hospitals.

But her remarkable and disturbing history ultimately illuminates another 
hidden hydrocarbon holocaust. Our frightful addiction to fossil fuels has 
not only fouled the atmosphere but given us a wealth of chemicals, plastics 
and technologies that increasingly undoes the health of millions with 
cancers. It, too, has given us rich armies of PR men employing "the same 
expert public relations strategies that kept us tied in knots on tobacco."

Davis knows that changing medical perspectives and priorities, from 
treatment to prevention, will be an enormous task. But she does not despair. 
In fact she ends her book with a simple Talmudic story. Faced with a 
complicated assignment, a group of workers rhyme off the usual excuses: They 
haven't got the tools or they haven't got the energy. But a good rabbi 
(sounding much like Gandalf in The Lord of the Rings) sets them straight: 
"It is not for you to complete the task," he says. "But you must begin."

Davis's masterful book has shown us why we must begin rethinking cancer 
research and treatment now for our children's sake.

Contributing reviewer Andrew Nikiforuk has written extensively about the 
cancerous legacy of uranium and oil sands mining in northern Canada. He is 
the author of Pandemonium, about how global trade and climate change 
threaten food security.